NCT06067555View on ClinicalTrials.gov

Intradermal Influenza Vaccination

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Vaccine Reaction
Interventions
DEVICE

MicronJet

MicronJet 600 syringe will be used to administer intradermal flu vaccine injections

BIOLOGICAL

Fluzone® Quadrivalent

Intradermal injections of 0.3mL

BIOLOGICAL

Fluzone® Quadrivalent

Intramuscular injection of 0.3mL

OTHER

Bacteriostatic Saline

Intradermal injection of 0.3mL (control)

Trial Locations (1)

06519

RECRUITING

Church Street Research Unit, New Haven

All Listed Sponsors
collaborator

Chan Zuckerberg Initiative

OTHER

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Silicon Valley Community Foundation

OTHER

collaborator

University of Chicago

OTHER

lead

Yale University

OTHER